These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24081151)

  • 1. Systemic mastocytosis accompanied by a non-secretory plasma cell dyscrasia and nephrotic syndrome-level proteinuria in a 76-year-old patient.
    Papadopoulou V; Ioannou S; Levidou G; Variami E; Kouzis P; Siakantaris M
    Acta Haematol; 2014; 131(2):78-83. PubMed ID: 24081151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of an acquired haemorrhagic diathesis due to factor X deficiency with chemotherapy.
    De Jager E; Bieger R; Castel A; Kluin PM
    Eur J Haematol; 2001 May; 66(5):352-4. PubMed ID: 11422417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
    Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
    Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic mastocytosis with plasma cell dyscrasia: report of a case.
    Pullarkat ST; Sedarat F; Paquette R; Said J
    Leuk Res; 2008 Jul; 32(7):1160-3. PubMed ID: 18061667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced intensity allogeneic stem cell transplantation for systemic primary amyloidosis refractory to high-dose melphalan.
    Kawai Y; Kinoshita K; Arai H; Kuwata A; Fukuoka Y; Yamaoka M; Imamura S; Tsutani H; Ueda T
    Eur J Haematol; 2004 Jun; 72(6):448-50. PubMed ID: 15128426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of acquired factor X deficiency with amyloidosis secondary to plasma cell dyscrasia.
    Mohri H
    Am J Hematol; 2004 Dec; 77(4):421-2. PubMed ID: 15551292
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary amyloidosis associated to severe factor X deficiency].
    Pérez Martínez J; Llamas F; López Montes A; Massó P; Poblet E; López Rubio E; Gallego E; Gómez Roldán C
    Nefrologia; 2004; 24(5):493-8. PubMed ID: 15648909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of aspiration biopsy of subcutaneous fat in amyloidosis].
    Ponce P; Carvalho F; Coelho A
    Nephrologie; 1986; 7(1):25-7. PubMed ID: 3960257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case of nephrotic syndrome due to AL-type primary amyloidosis associated with renal cell carcinoma].
    Takano M; Suda N; Ichihara A; Konishi K; Sasamura H; Hayashi K; Hashiguchi A; Miyajima A; Murai M; Itoh H
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1014-9. PubMed ID: 18186230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current approaches to the diagnosis and treatment of systemic mastocytosis.
    Bains SN; Hsieh FH
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotic syndrome secondary to amyloidosis.
    Kneipp S; Himmelstein SB
    Nurse Pract; 2000 Jun; 25(6 Pt 1):78, 81, 85-6 passim. PubMed ID: 10884998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mastocytosis: a rare entity.
    Syed NN; Moiz B
    J Pak Med Assoc; 2006 Jul; 56(7):338-40. PubMed ID: 16900719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of nephrotic syndrome associated with minimal renal amyloidosis--a four-year follow-up].
    Makibayashi K; Yanagita M; Kanatsu K
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):507-11. PubMed ID: 9283217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastocytosis and diffuse large B-cell lymphoma, an unlikely combination.
    Schipper EM; Posthuma W; Snieders I; Brouwer RE
    Neth J Med; 2011 Mar; 69(3):132-4. PubMed ID: 21444939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of primary amyloidosis with melphalan and prednisone.
    Schwartz RS; Cohen JR; Schrier SL
    Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm complete remission of AL-amyloid-related nephrotic syndrome.
    Fujigaki Y; Takahashi S; Yonemura K; Suzuki H; Togawa A; Fukasawa H; Goto T; Yamamoto T; Hishida A
    Clin Exp Nephrol; 2003 Sep; 7(3):250-3. PubMed ID: 14586724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].
    Horny HP; Krokowski M; Feller AC; Hintze G; Sotlar K; Valent P
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):222-8. PubMed ID: 12238313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome.
    Quitt M; Aghai E; David M; Kohan R; Ben Ari Y; Froom P
    Scand J Haematol; 1985 Aug; 35(2):155-7. PubMed ID: 3876596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.